EP3844189
DOSING STRATEGY THAT MITIGATES CYTOKINE RELEASE SYNDROME FOR CD3/CD20 BISPECIFIC ANTIBODIES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.8.2019EP published:
22.1.2025EP application number:
19782800.7
EPO information:
European Patent Register
Max expiry date:
29.8.2039
Title in English:
DOSING STRATEGY THAT MITIGATES CYTOKINE RELEASE SYNDROME FOR CD3/CD20 BISPECIFIC ANTIBODIESLanguage of the patent:
English
Timeline
Today
30.8.2019EP application
22.1.2025EP Publication
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
BROWNSTEIN, CarrieAddress:
New York, New York 10023, US
Name:
LOWY, IsraelAddress:
Tarrytown, New York 10591, US
Name:
ADRIAENS, Lieve LucilleAddress:
Tarrytown, New York 10591, US
Priority
Number:
201862726137 PDate:
31.8.2018Country:
US
Number:
201862774019 PDate:
30.11.2018Country:
US
Number:
201962861100 PDate:
13.6.2019Country:
US
Classification
Categories:
C07K 16/28, A61K 31/573, A61K 39/00